Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Prepaid Assets (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Prepaid Assets for 2 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 6.47% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, down 6.47% year-over-year, with the annual reading at $3.8 million for FY2025, 6.47% down from the prior year.
  • Prepaid Assets for Q4 2025 was $3.8 million at Pyxis Oncology, down from $5.3 million in the prior quarter.
  • The five-year high for Prepaid Assets was $6.5 million in Q2 2025, with the low at $2.6 million in Q3 2024.